Aemetis, Inc. (NASDAQ:AMTX) Short Interest Up 5.4% in June

Aemetis, Inc. (NASDAQ:AMTX) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 5,710,000 shares, an increase of 5.4% from the May 31st total of 5,420,000 shares. Based on an average daily trading volume, of 697,900 shares, the short-interest ratio is presently 8.2 days.

Aemetis Price Performance

Shares of Aemetis stock opened at $3.14 on Friday. The company has a market cap of $139.42 million, a PE ratio of -2.68 and a beta of 1.32. The firm has a fifty day moving average price of $3.48 and a two-hundred day moving average price of $3.91. Aemetis has a fifty-two week low of $2.75 and a fifty-two week high of $8.99.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.15). The company had revenue of $72.63 million for the quarter, compared to analyst estimates of $78.74 million. Analysts expect that Aemetis will post -1.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Aemetis

In related news, Director John R. Block sold 51,580 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total value of $180,014.20. Following the completion of the sale, the director now directly owns 14,001 shares in the company, valued at approximately $48,863.49. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 16.44% of the company’s stock.

Institutional Trading of Aemetis

Institutional investors have recently modified their holdings of the company. SG Americas Securities LLC bought a new stake in Aemetis in the first quarter valued at about $60,000. State Board of Administration of Florida Retirement System acquired a new stake in Aemetis during the first quarter valued at approximately $84,000. Citigroup Inc. grew its stake in shares of Aemetis by 10,391.3% in the 3rd quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock valued at $311,000 after purchasing an additional 74,298 shares during the period. Finally, Stifel Financial Corp raised its holdings in shares of Aemetis by 58.0% in the 3rd quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock worth $2,870,000 after buying an additional 253,745 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Analyst Ratings Changes

AMTX has been the subject of several recent analyst reports. StockNews.com raised shares of Aemetis to a “sell” rating in a report on Monday, June 3rd. HC Wainwright restated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Friday, May 10th. Finally, Truist Financial reiterated a “hold” rating and issued a $4.00 price objective (up from $3.50) on shares of Aemetis in a research note on Monday, May 13th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $12.25.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.